Medical Marketing & Media - News, Features & Insights
The latest on medical marketing. News, analysis, features, and insights for leaders, marketers, and creatives involved in promoting and commercializing prescription medicines, products, and services.
2024 MM+M Awards: All the winners
To view the digital edition of the 2024 MM+M Awards Book of the Night click here.. First, an introduction. I’m Jameson Fleming, the new editor-in-chief at MM+M.I come to this storied Haymarket publication from another legacy brand, Adweek, where I spent more than eight years learning the advertising and marketing industry inside and out.
Activating omnichannel without omniburden - Partner Content
Nov 19, 2024 · Research continues to prove that omnichannel marketing efforts outperform traditional marketing benchmarks. In fact, MM+M’s 2024 Healthcare Marketers Survey shows the average marketing spend surged 19.7% in 2023 to $9.1 …
MM+M’s favorite and most impactful stories of 2024
Dec 17, 2024 · The year is coming to a close and we here at MM+M are in a reflective mood. Taking a look back on our coverage throughout 2024, we got to report on a number of developments that have reshaped the industry. From deals across the pharma, biotech and medical marketing spaces, to executive changes ...
Large Healthcare Agency of the Year 2024 - MM+M Awards
Silver. The Weber Shandwick Collective. Committed to delivering impactful, innovative solutions that help clients navigate an ever-evolving healthcare landscape, this agency stands out for its global footprint, use of AI and truly astonishing public relations prowess.
About MM+M - MM+M - Medical Marketing and Media
MM+M, first published in 1966 as Medical Marketing + Media, is the media brand of record for pharmaceutical marketing and commercialization, delivering the most balanced and relevant coverage of its subject matter. The 57-year-old business title produces an essential mix of online breaking news and analysis combined with monthly print features — timely, objective, original editorial content ...
Agency 100 2024: ConcentricLife - MM+M
Jun 11, 2024 · In 2023, ConcentricLife's revenue climbed 16% to an MM+M-estimated $92.5 million. Learn more about the agency's year in its Agency 100 profile.
Using personal insights to create one-on-one connections
Nov 25, 2024 · The biopharma industry is in the midst of shifting toward personalized engagement with patients and healthcare providers (HCPs). This tailored approach will enable firms to make better use of precious marketing dollars.
Rare Disease Agency of the Year 2024 - MM+M Awards
Gold. Havas Life Rare. Havas Life Rare, formerly H4B Boston, wins gold again this year for its outstanding work as a commercialization and marketing partner for orphan drugs and rare disease markets.
Five things for pharma marketers to know for Thursday morning
3 days ago · Novartis said its gene therapy helps children with rare muscle disorder in a new study. The therapy helped improve motor function in children with a rare muscle disorder where symptoms include difficulty walking, talking and swallowing. (Reuters) Axsome said it will still seek approval from the Food ...
- Some results have been removed